Skip to main content

Table 8 Comparison between raw prevalence rates of COVID-19 cases among Lombardy general population and Lombardy population with HHT

From: Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy

Lombardy region

General population

Susceptible Populationa

   

COVID-19 positive in general population

Only cases with swab molecular confirmationb

Observed Raw prevalence rate in general population

Only cases with swab molecular confirmationb

10,027,602

   

93,901

1:107

HHT

 

Observed COVID-19 positive cases in HHT

Observed Raw prevalence rate in HHT

Observed Raw prevalence rate in HHT

Observed COVID-19 positive cases in HHT

Observed Raw prevalence rate in HHT

 

Serol. confirmation, irrespective of swab molecular confirmationb

Serol. confirmation, irrespective of swab molecular confirmationb

(Susceptible population: Respondents only = 63)

Serol. confirmation, irrespective of swab molecular confirmationb

(Susceptible population: Non-Respondents included = 131)

Only cases with swab molecular confirmationb

Only cases with swab molecular confirmationb

(Susceptible population: Non-Respondents included = 131)

 

8

8/63 (12.7%)

1:7.87

8/131 (6.1%)

1:16.37

3

3/131 (2.29%)

1:43.67

  1. Susceptible population is indicated in bold
  2. (aISTAT, 2019, Dec 31st) (Lombardy population, 2020)
  3. bCases reported at the end of study period: (2020, June 30th)